Debating Small Differences
The European Court of Justice has been wrestling with a set of sticky questions: to what extent should the existence of a new version of a drug influence what becomes of a previous version? The case that is raising these issues was filed by Rhone-Poulenc Rorer in June 1997, as a protest against a decision by the UK Medicines Control Agency, which granted a parallel import license for an old version of RPR's insomnia treatment zopiclone.
You may also be interested in...
Gene therapy remains attractive when data show new technologies can advance the field, but gene regulation, editing and RNA therapies are grabbing investors’ attention, panelists said at ARM’s Cell and Gene Meeting on the Mesa.
Gilead looks set to expand its lead position in the triple-negative breast cancer (TNBC) market in Europe with a positive opinion for Trodelvy from the CHMP.
Company seeks to avoid Medicaid “best price” implications by administering the program through an insurance policy with AIG, which is handling claims for refunds and processing payments.